Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancer

ConclusionThese studies further validate RALA as a genetic cargo delivery vehicle and iNOS as a potent therapy for the treatment of cancer.
Source: Cancer Nanotechnology - Category: Cancer & Oncology Source Type: research